Provider
The "game-changer" acquisition will integrate the Auckland-based company's healthcare data capabilities with AI.
The project specifically targets oral health issues among the elderly.
Industry leaders weigh in on notable topics that affected healthcare from data security to health system consolidation.
The Hyodol doll, widely marketed as a companion to solo-living seniors, has been registered with the US FDA.
Western Sydney Diabetes adopts the mobile solution to automate patient engagement.
It has comparable safety outcomes to coronary artery intervention guided by expensive 3D imaging.
It intends to make emerging technologies such as generative AI and mixed reality accessible to people with disabilities.
Musk revealed on X that the SEC has reopened its investigation into Neuralink, sharing a letter from his attorney addressed to the commission's chair.
The funding brings the company's Series C funding round to a close and total capital raised to $155 million.
The company will use the funds to accelerate the development of its Ellipse Spinal Cord Stimulator Platform, used to treat chronic pain.